Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
213 participants
OBSERVATIONAL
2001-07-31
2009-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Social Support and Myocardial Ischemia
NCT00005449
Quality of Life in Patients With Chronic Ischemic Heart Disease
NCT00005671
Montreal Heart Attack Readjustment Trial (M-HART)
NCT00000533
Risk Factors for Predictors of In-hospital Death in Acute Fulminant Myocarditis
NCT03219996
Cardiovascular Risk Assessment Model in Patients With MI
NCT03957005
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Our primary objective is to determine among patients hospitalized for a myocardial infarction, the impact of emotional support on functional outcomes at two years as measured by a valid measure of functional health, the SF-36.
Secondary Objectives:
Our secondary objectives are:
1. To determine the types of social support which are perceived as being most helpful to patients.
2. To determine whether women and minority patients have unique views on the types of support that are helpful.
3. To determine among patients admitted for myocardial infarction, the impact of social support on length of stay and hospital readmissions.
Hypothesis:
Our hypotheses are as follows:
1. Patients who are hospitalized for a myocardial infarction and who have high emotional support will have better long-term functional status compared to those patients who have low support.
2. Patients with high emotional support will be more likely to adhere to protocols such as taking their medications, keeping appointment, and enrolling in cardiac rehabilitation.
3. Patients with high emotional support will have lengths of hospitalization which are shorter than their estimated geometric mean as compared to patients who have low support.
4. The types of social support which are perceived as most helpful in disease management will be influenced by gender and ethnicity.
Long-term Objectives:
The long-term objective is to determine the mechanisms by which social support impacts on functional health and to utilize this data to develop future interventions that can be targeted toward a culturally and ethically diverse cohort of patients with coronary artery disease. Overall, the goal is to use this data to prevent functional disability and improve quality of life among patients with coronary artery disease.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Robert Wood Johnson Foundation
OTHER
Weill Medical College of Cornell University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Weill Cornell Medical College
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Carla Boutin-Foster, MD
Role: PRINCIPAL_INVESTIGATOR
Joan and Sanford I. Weill Medical College
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
042677
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.